Science Explorer Interactive view Map
Company · Shenzhen · China

Shenzhen Bioeasy Biotechnology (China)

en.bioeasy.com.trROR OpenAlex
World rank, 2022–2025
#17,174
of 28,054 · #30,369 all time
Rank in China
#2,639
of 3,058
Research works
142
▲ 1227% vs 2013–17
Citations
2.4k
16.8 per fractional work
Top-10% rate
16.9%
record average 16.5%
Open access
36%
world 28%

What does Shenzhen Bioeasy Biotechnology (China) specialise in?

Where its research is concentrated relative to its size: Biochemistry, Genetics and Molecular Biology takes 6.6× the share of its output that it takes of world research.

  1. Biochemistry, Genetics and Molecular BiologyField · 25.2 works6.6×
← less than its size predicts1×more →

Location quotient, a volume reading rather than an impact one. It surfaces small, lopsided specialities.

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.93× its world share, 3 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 6.57× its world share, 25 worksBiochemistry, Geneti…Immunology and Microbiology: 2.44× its world share, 2 worksImmunology and Micro…Neuroscience: 0.31× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 0.37× its world share, 0 worksPharmacology, Toxico…Chemistry: 1.89× its world share, 2 worksChemistryComputer Science: 0.30× its world share, 2 worksComputer ScienceEarth and Planetary Sciences: 0.15× its world share, 0 worksEarth and Planetary …Engineering: 0.34× its world share, 4 worksEngineeringEnvironmental Science: 0.76× its world share, 3 worksEnvironmental ScienceMaterials Science: 0.35× its world share, 1 worksMaterials SciencePhysics and Astronomy: 0.07× its world share, 0 worksPhysics and AstronomyMedicine: 2.16× its world share, 30 worksMedicineNursing: 0.16× its world share, 0 worksNursingVeterinary: 0.68× its world share, 0 worksVeterinary1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 6.6×. Every wedge is a field page.

Which keywords describe research at Shenzhen Bioeasy Biotechnology (China)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Targeted Therapy, Genomic Instability, Cell-Free DNA, Cancer Genomics, Mutational Signatures, Cancer, Tumor Microenvironment and Clinical Trials.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Targeted Therapy15▲ 93×3 topics
  2. Genomic Instability11▲ 135×3 topics
  3. Cell-Free DNA10▲ 146×2 topics
  4. Cancer Genomics10▲ 195×1 topic
  5. Mutational Signatures10▲ 195×1 topic
  6. Cancer7▲ 7.2×19 topics
  7. Clinical Trials5▲ 11×6 topics
  8. Tumor Microenvironment5▲ 16×8 topics
  9. Chemotherapy5▲ 9.6×12 topics
  10. Genomic Profiling4▲ 53×2 topics
  11. ALK Inhibitors4▲ 86×1 topic
  12. EGFR Mutations4▲ 86×1 topic
  13. Oxidative Stress3▲ 2.9×16 topics
  14. Gene Expression3▲ 7.4×9 topics
  15. Immunotherapy3▲ 6.0×12 topics
  16. Metastasis3▲ 11×6 topics
  17. Biomarkers2▲ 5.0×8 topics
  18. Precision Medicine2▲ 7.5×4 topics
  19. Immune Checkpoint Blockade2▲ 31×1 topic
  20. PD-1 and PD-L12▲ 31×1 topic
  21. Prognostic Factors2▲ 7.7×5 topics
  22. Cell Death2▲ 14×4 topics
  23. Epigenetic Regulation2▲ 15×4 topics
  24. Clinical Practice Guidelines2▲ 5.2×6 topics
  25. Long Noncoding RNAs2▲ 34×1 topic
  26. Molecular Characterization2▲ 17×4 topics
  27. RNA Regulation2▲ 27×1 topic
  28. Adjuvant Chemotherapy2▲ 37×2 topics
  29. Cancer Progression2▲ 15×2 topics
  30. Cancer Risk2▲ 12×3 topics
  31. Genetic Testing2▲ 23×2 topics
  32. Ferroptosis2▲ 33×1 topic
  33. Lipid Peroxidation2▲ 24×1 topic
  34. RNA methylation2▲ 28×1 topic
  35. m6A-seq2▲ 28×1 topic
  36. Hereditary Syndromes2▲ 77×1 topic
  37. Microsatellite Instability2▲ 77×1 topic
  38. Cetuximab2▲ 26×2 topics
  39. Fluorouracil1▲ 59×1 topic
  40. KRAS Mutations1▲ 59×1 topic

Which research topics does Shenzhen Bioeasy Biotechnology (China) publish most on?

By volume in 2022–2025: Cancer Genomics and Diagnostics, Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers and Cancer-related molecular mechanisms research.

Cancer Genomics and Diag…10Cancer Genomics and Diagnostics: 10 fractional worksLung Cancer Treatments and Mutations: 4 fractional worksCancer Immunotherapy and Biomarkers: 2 fractional worksCancer-related molecular mechanisms research: 2 fractional worksRNA modifications and cancer: 2 fractional worksFerroptosis and cancer prognosis: 2 fractional worksGenetic factors in colorectal cancer: 2 fractional worksColorectal Cancer Treatments and Studies: 1 fractional worksCancer Cells and Metastasis: 1 fractional worksCancer Diagnosis and Treatment: 1 fractional works
Cancer ResearchPulmonary and Respiratory MedicineOncologyMolecular Biology1 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Cancer Genomics and Diagnostics Cancer Research 10 works
  2. 2 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 4 works
  3. 3 Cancer Immunotherapy and Biomarkers Oncology 2 works
  4. 4 Cancer-related molecular mechanisms research Cancer Research 2 works
  5. 5 RNA modifications and cancer Molecular Biology 2 works
  6. 6 Ferroptosis and cancer prognosis Pulmonary and Respiratory Medicine 2 works
  7. 7 Genetic factors in colorectal cancer Pathology and Forensic Medicine 2 works
  8. 8 Colorectal Cancer Treatments and Studies Oncology 1 works
  9. 9 Cancer Cells and Metastasis Oncology 1 works
  10. 10 Cancer Diagnosis and Treatment Oncology 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.4%not open63.6%

World: 28% of research is openly available.

with international co-authors14.2%domestic only85.8%

World: 19% is written across borders.

How has Shenzhen Bioeasy Biotechnology (China)'s research output changed?

Output in 2018–2022 was 1227% higher than in 2013–2017.

20152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Shenzhen

All research institutions in Shenzhen

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.